These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37598332)

  • 1. Tenecteplase: More Evidence It Should Replace Alteplase for Ischemic Stroke Treatment.
    Kreitzer N
    Ann Emerg Med; 2023 Dec; 82(6):729-731. PubMed ID: 37598332
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenecteplase to Replace Alteplase? Comparing Thrombolytic Therapies for Acute Ischemic Stroke: June 2023 Annals of Emergency Medicine Journal Club.
    Hanna E; Barrett TW
    Ann Emerg Med; 2023 Jun; 81(6):759-760. PubMed ID: 37210165
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenecteplase versus alteplase for early treatment of ischaemic stroke - Authors' reply.
    Churilov L; Bivard A; Parsons MW
    Lancet Neurol; 2022 Nov; 21(11):959. PubMed ID: 36270302
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolving Thrombolytics: from Alteplase to Tenecteplase.
    Miller SE; Warach SJ
    Neurotherapeutics; 2023 Apr; 20(3):664-678. PubMed ID: 37273127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Tenecteplase for Acute Ischemic Stroke Treatment.
    Brown CS; Manuel FC; Mattson AE; Schmitt CJ; Hellickson JD; Clark SL; Wieruszewski ED
    J Emerg Nurs; 2024 Mar; 50(2):171-177. PubMed ID: 38069957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Ferguson E; Yadav K
    CJEM; 2023 Feb; 25(2):121-122. PubMed ID: 36577932
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenecteplase for acute ischaemic stroke.
    Sandset EC; Tsivgoulis G
    Lancet; 2022 Jul; 400(10347):138-139. PubMed ID: 35779556
    [No Abstract]   [Full Text] [Related]  

  • 8. IV tenecteplase: A non-inferior alternative to alteplase?
    Zubair AS; Sheth KN
    Med; 2022 Aug; 3(8):519-520. PubMed ID: 35963230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid for treatment of symptomatic hemorrhagic conversion following administration of tenecteplase for acute ischemic stroke.
    Hailu K; Ragoonanan D; Davis H
    Am J Emerg Med; 2022 Sep; 59():216.e1-216.e5. PubMed ID: 35750531
    [No Abstract]   [Full Text] [Related]  

  • 10. In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome.
    Ferguson E; Lang E
    Ann Intern Med; 2022 Nov; 175(11):JC124. PubMed ID: 36315948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Treatment of Ischemic Stroke.
    Lyden S; Wold J
    Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freezing Tenecteplase Into Aliquots to Reduce Waste in Acute Ischemic Stroke.
    Kaur H; Merkel A; Hackett CT; Finoli L; Seidl E; Reardon C; Cerejo R
    Stroke; 2024 Jan; 55(1):e1-e2. PubMed ID: 38063015
    [No Abstract]   [Full Text] [Related]  

  • 13. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.
    Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S
    Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Rose D; Cavalier A; Kam W; Cantrell S; Lusk J; Schrag M; Yaghi S; Stretz C; de Havenon A; Saldanha IJ; Wu TY; Ranta A; Barber PA; Marriott E; Feng W; Kosinski AS; Laskowitz D; Poli S; Mac Grory B
    Stroke; 2023 May; 54(5):1192-1204. PubMed ID: 36951049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Wang L; Hao M; Wu N; Wu S; Fisher M; Xiong Y
    J Am Heart Assoc; 2024 May; 13(9):e031692. PubMed ID: 38686848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise of tenecteplase in acute stroke: Within reach or beyond approval?
    Zachrison KS; Schwamm LH
    Med; 2022 Oct; 3(10):651-655. PubMed ID: 36202099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke.
    Huang X; Moreton FC; Kalladka D; Cheripelli BK; MacIsaac R; Tait RC; Muir KW
    Stroke; 2015 Dec; 46(12):3543-6. PubMed ID: 26514192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label tenecteplase use in spinal cord ischemia.
    Oliveira DS; Sousa L
    Acta Neurol Belg; 2023 Dec; 123(6):2409-2412. PubMed ID: 36892749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.